News
A report from the National Weather Service was issued on Wednesday at 4:42 p.m. for strong thunderstorms until 5:15 p.m. for ...
At 4.35pm a 21-year-old man allegedly stabbed a 54-year-old man after getting into an altercation at a Taringa St address in ...
Trans and LGBTQ+ community groups in the Chicago area expressed disappointment and anger about the U.S. Supreme Court’s ...
Read How Can Christians Stand Firm in a Culture of Confusion? by Judy McEachran and more articles about Church on ...
1d
FootballTransfers on MSNMan Utd transfer news: Marcus Rashford to make ‘HUGE EFFORT’ after making career-changing decisionMarcus Rashford continues to be a player on Manchester United’s transfer list after a fallout with head coach Ruben Amorim, ...
Key factors driving growth in the safety laser scanner market include rising industrial automation and rapid advancements in machine safety technologies, enhancing operational efficiency and safety.” ...
1d
Stars and Stripes FC on MSN2025 CONCACAF Gold Cup: Scouting HaitiT he 18 th edition of the Concacaf Gold Cup is well underway, with 16 nations vying to take home the trophy at the region’s ...
On Thursday, June 19, 2025, in the 3rd and final qualifying round of the CONCACAF Gold Cup, our Grenadiers faced the Soca ...
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. The company’s development product portfolio includes ...
A stunning silhouette and a capable build make the new Aspero 5 a compelling gravel race machine. The Aspero 5’s stunning ...
Gilead Sciences has forged closer ties to its cancer drug partner Arcus Biosciences , although a licensing deal doesn't go as far as the takeover that some market commentators have been predicting.
Gilead and Arcus’ efforts to rebuild confidence in TIGIT as a drug target for cancer immunotherapies have shuffled forwards again, with new data showing signs of efficacy in a combination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results